ZALTRAP 25MG/ML CONC. VIAL FOR INF. 8 ML

ZALTRAP IN COMBINATION WITH FLUOROURACIL LEUCOVORIN IRINOTECAN-(FOLFIRI) IS INDICATED FOR PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) THAT IS RESISTANT TO OR HAS PROGRESSED FOLLOWING AN OXALIPLATIN-CONTAINING REGIMEN.